The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases
- PMID: 25009800
- PMCID: PMC4070060
- DOI: 10.3389/fonc.2014.00151
The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases
Abstract
Image guidance allows delivery of very high doses of radiation over a few fractions, known as stereotactic ablative radiotherapy (SABR). This treatment is associated with excellent outcome for early stage non-small cell lung cancer and metastases to the lungs. In the delivery of SABR, central location constantly poses a challenge due to the difficulty of adequately sparing critical thoracic structures that are immediately adjacent to the tumor if an ablative dose of radiation is to be delivered to the tumor target. As of current, various respiratory motion management and image guidance strategies can be used to ensure accurate tumor target localization prior and/or during daily treatment, which allows for maximal and safe reduction of set up margins. The incorporation of both may lead to the most optimal normal tissue sparing and the most accurate SABR delivery. Here, the clinical outcome, treatment related toxicities, and the pertinent respiratory motion management/image guidance strategies reported in the current literature on SABR for central lung tumors are reviewed.
Keywords: SABR; central location; metastases; non-small cell lung cancer; stereotactic ablative radiotherapy.
Similar articles
-
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453. J Thorac Oncol. 2015. PMID: 25514807 Review.
-
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.J Thorac Oncol. 2011 Dec;6(12):2036-43. doi: 10.1097/JTO.0b013e31822e71d8. J Thorac Oncol. 2011. PMID: 21892102
-
Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases.Cancers (Basel). 2021 Apr 1;13(7):1636. doi: 10.3390/cancers13071636. Cancers (Basel). 2021. PMID: 33915810 Free PMC article. Review.
-
Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors.Radiol Oncol. 2020 Jun 26;54(4):480-487. doi: 10.2478/raon-2020-0039. Radiol Oncol. 2020. PMID: 32589607 Free PMC article.
-
Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea.Cancer Res Treat. 2017 Jul;49(3):688-694. doi: 10.4143/crt.2016.219. Epub 2016 Oct 31. Cancer Res Treat. 2017. PMID: 27809459 Free PMC article.
Cited by
-
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.Radiat Oncol. 2023 Jun 7;18(1):97. doi: 10.1186/s13014-023-02286-5. Radiat Oncol. 2023. PMID: 37287020 Free PMC article.
-
Life-threatening hemoptysis in patients with metastatic kidney cancer.Clin Genitourin Cancer. 2023 Aug;21(4):497-506. doi: 10.1016/j.clgc.2023.01.011. Epub 2023 Feb 1. Clin Genitourin Cancer. 2023. PMID: 37045713
-
The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study.Front Oncol. 2022 Oct 14;12:921473. doi: 10.3389/fonc.2022.921473. eCollection 2022. Front Oncol. 2022. PMID: 36313653 Free PMC article.
-
[Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):413-418. doi: 10.3779/j.issn.1009-3419.2018.05.10. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29764593 Free PMC article. Review. Chinese.
-
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.Radiother Oncol. 2017 Jun;123(3):346-354. doi: 10.1016/j.radonc.2017.05.007. Epub 2017 May 22. Radiother Oncol. 2017. PMID: 28545956 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
